SBIR/STTR Research Award

Macrolide Discovery through Glycosylation

Award identifier 6b507283da6340bf9bc227bdfcc0c3872b6b3cc065b0b81b6976cd32b62cbc0eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2004

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Open in CaptureIQRequest Access

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
OPTIMER PHARMACEUTICALS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2004-2
Topic code
Not reported

Research abstract

Macrolide antibiotics have been marketed since the early 1950's and have a history of being safety and efficacious. These molecules inhibit protein synthesis by interacting with bacterial ribosomal RNA subunits. The recent emergence of macrolide resistanc

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSoloChatGPTClaudePerplexityGrokGemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.